Medicine guide
Ryeqo
·
- Prescription status not stated
- Hormones, such as thyroid and steroids
- Active substance
- Relugolix;estradiol;norethisterone acetate
- Made by
- Gedeon Richter Plc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Ryeqo is indicated in adult women of reproductive age for: treatment of moderate to severe symptoms of uterine fibroids, symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Gedeon Richter Plc. |
|---|---|
| Active substance | Relugolix;estradiol;norethisterone acetate |
| Used in | Hormones, such as thyroid and steroids |
| Classification | H01CC54 · Hormones, such as thyroid and steroids |
| Authorised on | 2021-07-16 |
| Last updated by the regulator | 2026-08-20 |
| EMA product number | EMEA/H/C/005267 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).